Journal of Pulmonology and Clinical Research

Perspective P.1-2

Diverse, effective strategies for copd management.

Author(s):

Olivia P. Williams*

Perspective P.1-2

Asthma exacerbations: Triggers, management, personalization.

Author(s):

Robert H. Jenkins*

Perspective P.1-2

Post-tuberculosis fibrosis: Global burden and neglect.

Author(s):

Ayesha Patel*

Perspective P.1-2

Targeted drug delivery redefines pah treatment.

Author(s):

Ethan M. Torres*

Perspective P.1-2

Pulmonary rehab & spirometry: Evolving copd care.

Author(s):

Clara Martinez*

Opinion Article P.1-2

Integrating smoking cessation with lung cancer screening.

Author(s):

Hiroshi Tanaka*

Opinion Article P.1-2

Asthma management: Objective assessment and personalized therapy.

Author(s):

Nadia Al Mansour*

Opinion Article P.1-2

Respiratory health: Pathogenesis, diagnosis, treatment.

Author(s):

Martin Kowalski*

Opinion Article P.1-2

Cystic fibrosis management: Exercise, rehab, ventilation.

Author(s):

Sophia Lee*

Opinion Article P.1-2

Evolving ards & respiratory failure therapies.

Author(s):

Amir Khosravi*

Short Communication P.1-1

Role of Fine Needle Aspiration Cytology in Diagnosis of Chest Lesions

Author(s): Bashar Hanna Azar

Short Article P.2-2

Role of CHVs in Improving on Prevention and Control of Pneumonia in Nairobi County, Kenya

Author(s): Bryson Sifuma

DOI: 10.35841/pulmonology-clinical.4.2.2-2

Short Article P.1-1

Perplexing transudative pleural effusions – not anymore: an interesting case series

Author(s): Vaibhav Chachra

DOI: 10.35841/pulmonology-clinical.4.2.1-1

Case Report P.1-2

Pneumonia: Antimicrobial resistance and management challenges.

Author(s):

Maria Lopez-Gomez*

Case Report P.1-2

Bal: Guiding ipf diagnosis, prognosis, treatment.

Author(s):

Seung-Hyun Kim*

Case Report P.1-2

Pulmonary rehabilitation: Vital for post-tb lung disease.

Author(s):

Tanya Patel*

Case Report P.1-2

Lung cancer screening: Evolution, diagnosis, challenges.

Author(s):

Victor Orlov*

Case Report P.1-2

Bronchodilators in cf: Individualized treatment strategy.

Author(s):

Elsa Johansson*

Commentary P.1-2

Ild: Better diagnosis, pathophysiology, and outcomes.

Author(s):

Matthew D. Cooper*

Commentary P.1-2

Ards: Injury, ventilation, and personalized management.

Author(s):

Isabella Romano*

Commentary P.1-2

Airway remodeling in asthma: Mechanisms and personalized therapy

Author(s):

Ahmed S. Al Farsi*

Commentary P.1-2

Pulmonary rehab: Advancing copd management & access.

Author(s):

Lucy M. Harrison*

Commentary P.1-2

Osa-ph: Cpap cornerstone, oxygen�s uncertain impact.

Author(s):

Nicolas Dubois*

Short Communication P.1-2

Lung cancer breakthroughs: Ai, biomarkers, targeted therapies.

Author(s):

Gabriel Santos*

Short Communication P.1-2

Sputum: Tailored treatments for chronic lung conditions.

Author(s):

Miriam Varela*

Short Communication P.1-2

Biomarkers: Respiratory infections, ards, clinical advances.

Author(s):

Jürgen Becker*

Short Communication P.1-2

Ards management: Advancements, personalization, outcomes.

Author(s):

Naomi Cohen*

Short Communication P.1-2

Smoking, inflammation, vascular disease: Quit now.

Author(s):

Javed Iqbal*

Short Communication P.1-2

Pulmonary hypertension in osa-copd overlap.

Author(s):

Laura Smith*

Short Communication P.1-2

Lung transplant: Infections, oxygen, outcomes.

Author(s):

Keiko Tanaka*

Short Communication P.1-2

Pulmonary rehab: Holistic care, lasting benefits.

Author(s):

Ahmed El Sharif*

Short Communication P.1-2

Feno: Guiding personalized copd management.

Author(s):

Pierre Lefevre*

Short Communication P.1-2

Transforming pediatric cf: Personalized respiratory care.

Author(s):

Alina Popescu*

Short Communication P.3-3

Adverse events in multi-drug resistant tuberculosis patients registered at DOTS-Plus site at AIIMS, New Delhi, India

Author(s): Gaurav Gupta

Short Communication P.2-2

Role of CHVs in Improving on Prevention and Control of Pneumonia in Nairobi City County, Kenya.

Author(s): Bryson Sifuma

Short Communication P.4-4

An Aerosolized Antimicrobial combination for the treatment of pulmonary Pseudomonas aeruginosa infection's.

Author(s): Hana DOUAFER

Rapid Communication P.1-2

Personalized respiratory care: Genes to digital health.

Author(s):

Samuel Hayes*

Rapid Communication P.1-2

Ipf lung transplant: Research, challenges, outcomes.

Author(s):

Linda Martinez*

Rapid Communication P.1-2

Ai-enhanced chest radiography for respiratory infections.

Author(s):

Ivan Petrov*

Rapid Communication P.1-2

Asthma remodeling: Ics, new therapies, personalized care.

Author(s):

Emma Johansson*

Rapid Communication P.1-2

Bronchiectasis: Ph, niv, and integrated management.

Author(s):

Thomas O’Connor*

Rapid Communication P.1-2

Lung cancer: Breath diagnostics and rehabilitation.

Author(s):

Manuela Rossi*

Rapid Communication P.1-2

Evolving respiratory care: Infections, guidelines, therapies.

Author(s):

Hiroshi Takahashi*

Rapid Communication P.1-2

Pjp in non-hiv immunocompromised: Management challenges.

Author(s):

Sophia Chen*

Rapid Communication P.1-2

Pulmonary rehab: Essential for copd recovery.

Author(s):

Mohamed Al Farsi*

Rapid Communication P.1-2

Global respiratory challenges: Infections and environment.

Author(s):

Ayesha Karim*

Short Article P.1-1

Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients –a phase 2 study

Author(s): Mark A Socinski

DOI: 10.35841/pulmonology-clinical.4.1.1-1

Research Article P.1-3

The Role of Fine Needle Aspiration Cytology In Diagnosis of Chest Lesions.

Author(s): Bashar Hanna Azar*

Abstract PDF